17 Capital Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,768
Closed -$881K 99
2021
Q3
$881K Hold
10,768
0.83% 43
2021
Q2
$982K Buy
+10,768
New +$959K 0.91% 39

Other funds holding NVS

17 Capital Partners's NVS Position: Q4 2021 in Review

17 Capital Partners sold out of Novartis (NVS) in Q4 2021, closing a stake of 10,768 shares — an estimated $881K sold.

17 Capital Partners first reported a position in NVS in Q2 2021 and held it in 2 quarters. The position peaked at $982K in Q2 2021. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • 17 Capital Partners reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
  • 17 Capital Partners sold 10,768 Novartis shares in Q4 2021, an estimated $881K.
  • 17 Capital Partners first reported a position in Novartis in Q2 2021 and held it in 2 quarters.
  • 17 Capital Partners's Novartis position peaked at $982K in Q2 2021.
  • 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on 17 Capital Partners's 13F filing for Q4 2021, filed 14 Jan 2022.